Fuller & Thaler Asset Mgmt (NASDAQ: INDV) holds 4.53M shares, 3.72%
Rhea-AI Filing Summary
Indivior Pharmaceuticals, Inc. ownership disclosure: Fuller & Thaler Asset Management, Inc. reports beneficial ownership of 4,529,583.47 shares of Common Stock, representing 3.72% of the class as reported in Amendment No. 1.
The filing states sole voting power of 4,351,663.47 shares and sole dispositive power of 4,529,583.47. The form is signed by the firm’s Chief Compliance Officer on 05/13/2026.
Positive
- None.
Negative
- None.
Insights
Large institutional stake disclosed: 4.53M shares (3.72%).
Fuller & Thaler reports beneficial ownership of 4,529,583.47 shares, equal to 3.72% of the class as of the amendment. The filing lists 4,351,663.47 shares with sole voting power and 4,529,583.47 shares with sole dispositive power.
Holdings at this scale can matter for shareholder composition; future filings may show position changes. Timing anchors: report header shows 03/31/2026 and signature date 05/13/2026.
Disclosure clarifies control and disposition authorities.
The amendment enumerates voting and dispositive powers, indicating the reporting entity exercises sole control over voting (4,351,663.47) and disposition (4,529,583.47) of the shares it reports. This is standard Schedule 13G/A detail on authority.
Because the reported stake is 3.72%, it falls below a 5% threshold referenced in the form. Any material change in percent or power would appear in subsequent amendments.